tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

SCPH Stock Latest News

scPharmaceuticals Holds Annual Stockholders Meeting June 2025
Company AnnouncementsscPharmaceuticals Holds Annual Stockholders Meeting June 2025
1M ago
8K
SCPH
scPharmaceuticals Earnings Call Highlights Growth and Expansion
PremiumCompany Announcements
scPharmaceuticals Earnings Call Highlights Growth and Expansion
2M ago
SCPH
scPharmaceuticals Reports Strong Q1 2025 Growth
PremiumCompany Announcements
scPharmaceuticals Reports Strong Q1 2025 Growth
2M ago
SCPH
Promising Growth Outlook for scPharmaceuticals Driven by Furoscix Expansion and Strong Market Demand
PremiumRatings
Promising Growth Outlook for scPharmaceuticals Driven by Furoscix Expansion and Strong Market Demand
2M ago
SCPH
scPharmaceuticals reports Q1 EPS (37c), consensus (28c)
PremiumThe Fly
scPharmaceuticals reports Q1 EPS (37c), consensus (28c)
2M ago
SCPH
scPharmaceuticals’ Earnings Call Highlights Growth and Challenges
PremiumCompany AnnouncementsscPharmaceuticals’ Earnings Call Highlights Growth and Challenges
4M ago
SCPH
Optimistic Buy Rating for scPharmaceuticals Amid Strong Q4 Results and Promising Developments
Premium
Ratings
Optimistic Buy Rating for scPharmaceuticals Amid Strong Q4 Results and Promising Developments
4M ago
SCPH
scPharmaceuticals price target lowered to $12 from $20 at Maxim
Premium
The Fly
scPharmaceuticals price target lowered to $12 from $20 at Maxim
4M ago
SCPH
Promising Growth Trajectory and Strategic Expansion Drive Buy Rating for scPharmaceuticals
PremiumRatings
Promising Growth Trajectory and Strategic Expansion Drive Buy Rating for scPharmaceuticals
4M ago
SCPH
Strong Growth Prospects for scPharmaceuticals: Buy Rating Justified by Furoscix Success and Strategic Expansion
PremiumRatings
Strong Growth Prospects for scPharmaceuticals: Buy Rating Justified by Furoscix Success and Strategic Expansion
4M ago
SCPH
scPharmaceuticals Reports Strong Revenue Growth in 2024
PremiumCompany Announcements
scPharmaceuticals Reports Strong Revenue Growth in 2024
4M ago
SCPH
scPharmaceuticals reports Q 4EPS (35c), consensus (39c)
PremiumThe Fly
scPharmaceuticals reports Q 4EPS (35c), consensus (39c)
4M ago
SCPH
Options Volatility and Implied Earnings Moves Today, March 19, 2025
PremiumMarket NewsOptions Volatility and Implied Earnings Moves Today, March 19, 2025
4M ago
KC
YY
Expanding Horizons: scPharmaceuticals’ Furoscix Gains FDA Approval for CKD, Broadening Market Potential
Premium
Ratings
Expanding Horizons: scPharmaceuticals’ Furoscix Gains FDA Approval for CKD, Broadening Market Potential
4M ago
SCPH
Strategic Market Expansion and Strong Sales Foundation Drive Buy Rating for scPharmaceuticals
Premium
Ratings
Strategic Market Expansion and Strong Sales Foundation Drive Buy Rating for scPharmaceuticals
5M ago
SCPH
scPharmaceuticals announces FDA approval of Furoscix indication expansion
PremiumThe Fly
scPharmaceuticals announces FDA approval of Furoscix indication expansion
5M ago
SCPH
Promising Outlook for scPharmaceuticals: Buy Rating Justified by Strong Demand and Strategic Initiatives
PremiumRatings
Promising Outlook for scPharmaceuticals: Buy Rating Justified by Strong Demand and Strategic Initiatives
5M ago
SCPH
scPharmaceuticals reports preliminary Q4 FUROSCIX revenue $12M-$12.3M
PremiumThe Fly
scPharmaceuticals reports preliminary Q4 FUROSCIX revenue $12M-$12.3M
6M ago
SCPH
scPharmaceuticals price target lowered to $12 from $16 at Craig-Hallum
PremiumThe Fly
scPharmaceuticals price target lowered to $12 from $16 at Craig-Hallum
8M ago
SCPH
scPharmaceuticals Reports Strong Growth in Q3 2024
PremiumCompany AnnouncementsscPharmaceuticals Reports Strong Growth in Q3 2024
8M ago
SCPH
scPharmaceuticals reports Q3 EPS (41c), consensus (30c)
Premium
The Fly
scPharmaceuticals reports Q3 EPS (41c), consensus (30c)
8M ago
SCPH
SCPH Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
SCPH Earnings Report this Week: Is It a Buy, Ahead of Earnings?
8M ago
SCPH

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >